TREM2 in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential
Cells · 05.09.2025 · 14 (17) · 1387
DOI: 10.3390/cells14171387 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 05.09.2025. Verfasst von Ling Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing 102218, Ch…. Hauptthemen laut MEDLINE: Receptors, Immunologic, Membrane Glycoproteins, Neurodegenerative Diseases. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS), represent significant global health challenges, affecting millions and straining healthcare systems. These disorders involve progressive neuronal loss and cognitive decline, with incompletely elucidated underlying mechanisms. Chronic neuroinflammation is increasingly recognized as a critical contributor to disease progression. The brain’s resident immune cells, microglia, are central to this inflammatory response. When overactivated, microglia and other immune cells, such as peripheral macrophages, can exacerbate inflammation and accelerate disease development. Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) is a transmembrane receptor of the immunoglobulin superfamily that demonstrates high expression on microglia in the central nervous system. TREM2 serves a vital role in regulating phagocytosis, synaptic pruning, and energy metabolism. This review examines the functions of TREM2 in neurodegenerative diseases and its potential as a therapeutic target, aiming to inform future treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing 102218, China.
- Key Laboratory of New Ceramics and Fine Processing, School of Materials Science and Engineering, Tsinghua University, Beijing 100084, China.
- Key Laboratory of Advanced Materials of Ministry of Education of China, School of Materials Science and Engineering, Tsinghua University, Beijing 100084, China.
ORCID-Profile: Ling Li
Zitieren
APA
Li, L., Zheng, X., Ma, H., Zhu, M., Li, X., Sun, X., & Feng, X. (2025). TREM2 in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential. Cells, 14(17), 1387. https://doi.org/10.3390/cells14171387
Vancouver
Li L, Zheng X, Ma H, Zhu M, Li X, Sun X, et al. TREM2 in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential. Cells. 2025;14(17):1387. doi:10.3390/cells14171387
BibTeX
@article{Li2025,
author = {Li, Ling and Zheng, Xiaoxiao and Ma, Hongyue and Zhu, Mingxia and Li, Xiuli and Sun, Xiaodan and Feng, Xinhong},
title = {TREM2 in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential},
journal = {Cells},
year = {2025},
volume = {14},
number = {17},
pages = {1387},
doi = {10.3390/cells14171387}
}
EUVIMED